Profile
Pascal Birman is currently the Chief Medical Officer at PHAXIAM Therapeutics SA since 2023.
Prior to this, he worked as the Medical Director at Pherecydes Pharma SA and as the Deputy Chief Medical Officer at Genfit SA.
Pascal Birman active positions
| Companies | Position | Start |
|---|---|---|
| PHAXIAM THERAPEUTICS S.A. | Chief Tech/Sci/R&D Officer | 2023-06-22 |
Former positions of Pascal Birman
| Companies | Position | End |
|---|---|---|
| GENFIT | Corporate Officer/Principal | - |
| PHERECYDES PHARMA | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GENFIT | Health Technology |
| PHAXIAM THERAPEUTICS S.A. | Health Technology |
| Private companies | 1 |
|---|---|
Pherecydes Pharma SA
 Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Pherecydes Pharma SA is a biotechnology company, which engages in the research and development of anti-infective therapies based on the use of bacteriophages. It develops phage treatments of bacterial infections. The company was founded by Jerome Gabard and Manuel Gea in December 2006 and is headquartered in Romainville, France. | Health Technology |
- Stock Market
- Insiders
- Pascal Birman
